Position in FTRE
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$3,060,033
+$1,402,895 QoQ
Shares Held
175,864
-0.0% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#63
of 333 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sequoia Financial Advisors, LLC holds $32,926,453 across 49 Biotechnology names. FTRE ranks #2 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,729 | $8,309,796 | |
| 2 | FTRE |
Fortrea Holdings Inc.
This page
|
175,864 | $3,060,033 | |
| 3 | INCY |
Incyte Corp
|
19,250 | $2,182,180 | |
| 4 | ARGX |
Argenx SE
|
2,045 | $1,897,289 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,687 | $1,675,451 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,347 | $1,308,577 | |
| 7 | EXEL |
Exelixis, Inc.
|
20,292 | $1,104,087 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
4,527 | $1,090,871 |
All Filings in FTRE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,060,033 | 175,864 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $1,657,138 | 175,917 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,033,585 | 175,860 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,479,899 | 175,760 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $870,225 | 176,159 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,316,395 | 174,357 | Shares | Sole | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||